Health Economics &
Outcomes Research


Health technology assessment (HTA) agencies and payers worldwide increasingly demand evidence of economic value for approval and market access of novel drugs, devices, and diagnostics. Avalon researchers and consultants have extensive knowledge and experience in the field of health economics and outcomes research (HEOR). These services include a wide variety of offerings across the product development continuum in pharmaceuticals, biotechnology, devices, and diagnostics. In the early stages of development, we provide insights and analysis on potential market size and the design of rigorous economic evaluations, such as clinical studies and cost-effectiveness analysis. In later stages of development, we can offer more in-depth analyses to support expanded market access. We are uniquely skilled in what we call “HEOR Analytics,” which includes novel statistical analyses of HEOR data, such as trial data or quality of life data, and novel applications of those analyses to statistical and economic models.

Types Of Engagements

  • Building cost offset and cost impact models for novel diagnostics
  • Cost-effectiveness analyses and budget impact analyses in oncology
  • Cost offset and cost impact models in treatment for kidney disease
  • Economic evaluation of liquid biopsies
  • Budget impact model of a novel drug
  • Global model adaptations
  • Survival analysis in outcomes research
  • Cost effectiveness analysis of combination drugs
  • Developing value propositions for novel medical devices
  • Mendelian randomization to assess causative factors in obesity
  • Conceptual models of disease progression & treatment of chronic obstructive pulmonary disease
  • Novel analysis of real-world data (RWD) to support HTA submissions
  • Estimation of market size for medical devices, diagnostics, & pharmaceuticals
  • Systematic & comprehensive summaries of literature & evidence
  • Publications in peer-reviewed journals

Key Staff

  • John Schneider, PhD
  • Andrew Briggs, DPhil, MSc
  • Robert Ohsfeldt, PhD
  • Jacie Cooper, MS
  • Anthony LoSasso, PhD

Related Markets & Industries

  • Insurance & Third-Party Payers
  • Medical Services
  • Hospitals & Health Systems
  • Pharmaceuticals & Biotechnology
  • Medical Devices & Diagnostics
  • Private Equity & Venture Capital
  • Consumer Products
  • Public Health
  • Government

Related Publications

Related Issue Briefs